Krayem, M., Sabbah, M., Najem, A., Wouters, A., Lardon, F., Simon, S., . . . Van Gestel, D. (2019). The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. Cancers (Basel).
シカゴスタイル引用形Krayem, Mohammad, et al. "The Benefit of Reactivating P53 Under MAPK Inhibition On the Efficacy of Radiotherapy in Melanoma." Cancers (Basel) 2019.
MLA引用形式Krayem, Mohammad, et al. "The Benefit of Reactivating P53 Under MAPK Inhibition On the Efficacy of Radiotherapy in Melanoma." Cancers (Basel) 2019.
警告: この引用は必ずしも正確ではありません.